NasdaqGS - Nasdaq Real Time Price USD
Unity Biotechnology, Inc. (UBX)
0.9911
+0.0051
+(0.52%)
As of 3:56:25 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-20,865
-20,865
-37,088
-52,414
-45,060
Investing Cash Flow
8,565
8,565
60,495
-24,545
39,313
Financing Cash Flow
77
77
-16,340
56,240
20,845
End Cash Position
8,476
8,476
20,699
13,632
34,351
Interest Paid Supplemental Data
--
--
1,969
2,204
2,370
Capital Expenditure
-66
--
-11
-96
-195
Issuance of Capital Stock
--
--
5,107
58,065
18,572
Repayment of Debt
--
--
-20,000
--
-68
Free Cash Flow
-20,865
-20,865
-37,099
-52,510
-45,255
12/31/2021 - 5/3/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XOMA XOMA Royalty Corporation
24.06
+3.08%
SER Serina Therapeutics, Inc.
5.90
+2.08%
BOLD Boundless Bio, Inc.
1.5200
-3.80%
SAGE Sage Therapeutics, Inc.
7.79
+2.17%
NKTR Nektar Therapeutics
0.7308
+6.56%
XBIT XBiotech Inc.
2.9650
-6.17%
6855.HK Ascentage Pharma Group International
50.650
+11.32%
VANI Vivani Medical, Inc.
1.0300
0.00%
ACET Adicet Bio, Inc.
0.6143
+2.14%
PTGX Protagonist Therapeutics, Inc.
44.89
-2.75%